TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
TVRD
163 hedge funds and large institutions have $166M invested in Tvardi Therapeutics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 37 increasing their positions, 58 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
163
Holders Change
+4
Holders Change %
+2.52%
% of All Funds
2.61%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
31
Increased
37
Reduced
58
Closed
26
Calls
$644K
Puts
$135K
Net Calls
+$509K
Net Calls Change
-$263K
Top Buyers
1 |
Citadel Advisors
Miami,
Florida
|
+$1.86M |
2 |
Squarepoint
New York
|
+$961K |
3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$905K |
4 |
Two Sigma Investments
New York
|
+$804K |
5 |
Tudor Investment Corp
Stamford,
Connecticut
|
+$655K |